In this video Dr. Berends discusses the impact of biliopancreatic limb length on weight loss when performing a Roux-en-Y gastric bypass for morbidly obese patients, according to the results of his randomized trial, the Elegance Trial.

We were delighted to welcome Professor Johan Askling, Karolinska Institutet, to our meeting in Nice to discuss the role of big data in surgical practice.

In this lecture, Jan J. De Waele explains how different antimicrobial resistances are produced and how this problem can be improved by integrating antimicrobial stewardship strategies in clinical practice, upholding the best antibiotic empirical therapy while reducing antibiotic consumption.

In this excellent presentation, Abdelrahman A. Nimeri reviews the concepts of weight loss and the long-term consequences of the most common bariatric procedures. He also explains the currents trends in the treatment of superobese patients.

ESCP were delighted to host a joint session with EHTG (European Hereditary Tumour Group) on hereditary colorectal cancer. Part of this session saw Matthias Kloor present on ‘SI, HNPCC, Lynch syndrome and immunotherapy including vaccine: an update’

Details of neoadjuvant treatment in esophageal cancer: why, when, and how to use it? We will go into the details of big trials such as the FLOT and CROSS studies. Finally, we will discuss the new drugs and the importance of targeted therapies.

The rise in the demand for liver donors in end-stage liver disease has led to a search for new sources, such as the non-heart beating donation or donation after cardiac arrest. Its importance has been growing in the last decades and it now is a significant source of organs along with the donation after brain death. We briefly review the main characteristics of this type of donation.

ESCP welcomed Professor Hongwei Yao, President of the Chinese Society of Coloproctology, to our meeting in Nice to deliver a session, ‘TaTME in China: from clinical practice to clinical research’.

Gallbladder cancer is one of the most common biliary malignancy. It is often diagnosed incidentally in the setting of a cholecystectomy for a benign disease. The majority of patients present with early-stage disease and a simple cholecystectomy may be enough. Other patients may benefit from more extended resections.

Surgical site infections (SSIs) are infections of an incision, organ, or space that occur after surgery. Most wound infections are caused by contamination with the patient’s own micro-organisms during surgery. Intraoperative surgical site irrigation is a common practice in surgical procedures in general, with all disciplines advocating some form of irrigation before incision closure. This is intended to reduce SSI, using different types of agents such as antibiotics and antiseptics. This practice, however, has been neither standardized nor is there compelling evidence that it effectively reduces the risk of surgical site infection (SSI).